#TOIIW

StockTitan

@stocktitan.net

3 days ago

The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 The Oncology Institute (NASDAQ: TOI) reported Q4 2025 revenue of $142.0M (+41.6%) and full-year 2025 revenue of $502.7M (+27.8%), with gross profit of $76.4M for 2025 (+41.6%).Q4 adjusted EBITDA was $0.15M, full-year adjusted EBITDA was $(12.4)M, net loss for 2025 was $(60.6)M, and cash totaled $33.6M as of Dec 31, 2025. 2026 guidance: revenue $630–650M, gross profit $97–107M, adjusted EBITDA $0–9M, free cash flow $(15)–5M.The company expects ~$150M in capitated revenue in 2026 and anticipates Q1 2026 adjusted EBITDA of $(1)M to $(3)M due to seasonality and reimbursement timing.

#TOI #TOIIW The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

2 weeks ago

March 12: The Oncology Institute 2025 results and investor call Fourth-quarter and full-year 2025 results will be released March 12, followed by a 5 p.m. ET conference call with webcast and replay available through March 19.

#TOI #TOIIW The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

4 months ago

#TOI #TOIIW The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

4 months ago

Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration Ascertain and The Oncology Institute (NASDAQ: TOI) announced a co-development to deploy a “near-touchless” prior authorization workflow using Ascertain’s Unified Payer Portal.The joint team moved from signed statement of work to a live early-stage deployment in eight weeks, with the system live since September 2025. Pilot sites saw a >80% reduction in office-visit authorization submission time and the program freed hundreds of staff hours each week. The portal now processes prior authorizations across TOI’s 100+ clinics and affiliates. TOI estimates the initiative could yield up to $2 million in operating expense savings in 2026 as the solution scales to additional authorization types.

#TOI #TOIIW Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration

www.stocktitan.net/news/TOI/ascertain-and-t...

StockTitan

@stocktitan.net

4 months ago

The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call The Oncology Institute (NASDAQ: TOI) will release its third quarter 2025 financial results after market close on Thursday, November 13, 2025.A company conference call will follow the same day at 5:00 p.m. Eastern Time, accessible by phone or simultaneous webcast on the company Investor Relations website. A replay will be available two hours after the call through Thursday, November 20, 2025. The passcode for both the live call and replay is 13756737.

#TOI #TOIIW The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

6 months ago

Leading Oncology Expert Dr. Santos to Head TOI's New Lung Cancer Center of Excellence in Florida The Oncology Institute establishes specialized lung cancer treatment center in Fort Lauderdale, led by renowned thoracic oncologist Dr. Edgardo Santos. Focus on value-based care and clinical trials.

#TOI #TOIIW The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

6 months ago

Leading Value-Based Cancer Provider TOI to Manage Oncology Care for South Florida Medicare Members The Oncology Institute will provide delegated utilization management and clinical advisory services to Doctors HealthCare Plans' Medicare Advantage members in South Florida, focusing on quality and cost control.

#TOI #TOIIW The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

7 months ago

Cancer Care Provider TOI's Pharmacy Business Surges 40% as Value-Based Model Gains Traction Community oncology group reports $119.8M Q2 revenue, driven by record pharmacy sales and 50,000 new capitated lives. Set to double Florida coverage through health plan expansion. See outlook.

#TOI #TOIIW The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

7 months ago

Leading Value-Based Oncology Group TOI Sets Q2 2025 Earnings Release for August 13 Major value-based oncology provider TOI announces Q2 2025 results release and investor call. Join the webcast or dial in for detailed financial insights. Get Details.

#TOI #TOIIW The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

8 months ago

The Oncology Institute Names Kristin England as Chief Administrative Officer The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, has appointed Kristin England as its new Chief Administrative Officer (CAO), effective July 7, 2025. In this newly created position, England will be responsible for overseeing Enterprise Central Business Operations and Technology Strategy across TOI's national operations.England joins TOI with over 20 years of healthcare management experience, previously serving as a senior executive at McKesson's US Oncology Network, where she specialized in revenue cycle optimization and practice management systems improvement. CEO Daniel Virnich emphasized that England's appointment comes at a crucial time as TOI focuses on scaling its MSO model and strengthening its value-based care approach.

#TOI #TOIIW The Oncology Institute Names Kristin England as Chief Administrative Officer

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

8 months ago

80,000 Nevada Medicaid Members Gain Exclusive Access to Premium Cancer Care Through Major Healthcare Partnership The Oncology Institute becomes exclusive cancer care provider for Nevada Medicaid members through SilverSummit partnership. Explore expanded healthcare access details.

#TOI #TOIIW The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

9 months ago

Major Market Milestone: The Oncology Institute Secures Spot in Both Russell 2000 and 3000 Indexes Leading value-based oncology group gains institutional recognition with dual Russell index inclusion. $10.6T in assets track these benchmarks. See growth impact.

#TOI #TOIIW The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

10 months ago

The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance The Oncology Institute (NASDAQ: TOI) reported strong Q1 2025 financial results. Revenue reached $104.4 million, up 10.3% year-over-year, with notable performance from their Retail Pharmacy and Dispensary segment contributing $49.3 million. The company posted a net loss of $19.6 million, slightly improved from $19.9 million in Q1 2024. TOI secured multiple capitated contract wins, adding over 100,000 lives across Florida, California, and Nevada markets. The company reaffirmed its 2025 guidance, projecting revenue of $460-480 million and gross profit of $73-82 million. TOI successfully raised $16.5 million through a private placement and expects to achieve cash flow positivity and profitability in the second half of 2025, with full-year profitability targeted for 2026.

#TOI #TOIIW The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

10 months ago

The Oncology Institute Taps Former Cigna National Oncology Director to Scale Value-Based Care Model Former Cigna Healthcare National Oncology Director to lead clinical strategy and MSO network expansion. Key hire accelerates value-based care partnerships. Learn more.

#TOI #TOIIW The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

10 months ago

Leading US Oncology Group TOI Readies Q1 2025 Financial Results: Key Details for May 14 Earnings Call Access TOI's latest oncology care performance metrics. Join the May 14 earnings call at 5PM ET to explore Q1 2025 growth. Get insights now.

#TOI #TOIIW The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

10 months ago

The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials The Oncology Institute (NASDAQ: TOI) has announced an enterprise-wide expansion of its strategic partnership with Helios Clinical Research, building upon their existing collaboration in Florida. The expanded partnership aims to enhance access to cancer clinical trials across TOI's markets.The collaboration focuses on integrating clinical research into community oncology settings, with key benefits including: Increased patient access to leading-edge therapiesStreamlined study activation and enrollment processesEnhanced trial performance through unified oversightImproved infrastructure for regulatory and operational supportTOI CEO Daniel Virnich emphasized that this expansion will help scale their research infrastructure while maintaining focus on patient care. Chief Medical Officer Yale Podnos highlighted the initiative's goal of making clinical research a routine part of patient care across all markets, with a shared commitment to advancing health equity in oncology research.

#TOI #TOIIW The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

11 months ago

Healthcare Expansion: TOI Unveils Florida Cancer Network, Secures 80K Patient Contracts New Florida cancer care network combines with four value-based contracts adding 80,000 lives, including 42,000 Medicare Advantage patients. Full expansion details inside.

#TOI #TOIIW TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1

www.stocktitan.net/news/TOI/toi-launches-fl...

StockTitan

@stocktitan.net

11 months ago

The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 The Oncology Institute (NASDAQ: TOI) reported its Q4 and full-year 2024 financial results. Q4 highlights include consolidated revenue of $100 million, up 16.9% year-over-year, with a net loss of $13.2 million compared to $18.8 million in Q4 2023. The company achieved positive cash flow from operations of $4.2 million in Q4.Key operational developments include a 12% reduction in SG&A expenses, new drug supplier agreements with improved discounts, and the launch of six new contracts covering over 250,000 lives. Value-based patient services increased by 15% from Q3 2024.For full-year 2024, TOI reported consolidated revenue of $393 million, a 21.3% increase, though patient services revenue decreased 4% due to a lost contract. The company expects Q1 2025 Adjusted EBITDA of $(5) to $(6) million, citing seasonal factors such as drug price increases and lower encounter volumes.

#TOI #TOIIW The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

11 months ago

Oncology Institute Lands Major $16.5M Backing as Insiders Double Down Strategic funding secured with management participation, plus $4.1M debt restructuring. Growth capital positions oncology leader for expansion. Full details inside.

#TOI #TOIIW The Oncology Institute Announces $16.5 million Private Placement

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

1 year ago

When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors TOI will release Q4 and full year 2024 financial results on March 25, 2025, after market close, followed by a 5:00 PM ET conference call.

#TOI #TOIIW The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

1 year ago

The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown The Oncology Institute (NASDAQ: TOI) has announced key financial developments, including an amendment to its facility agreement with Deerfield Management Company and a partial debt reduction. The amendment removes the $40 million minimum cash covenant and lifts restrictions on equity offerings. TOI has paid down approximately $20 million of senior secured convertible notes and related interest.The company has also reported significant progress in its growth initiatives, having secured three new capitation agreements in 2025, adding roughly 80,000 lives across California, Nevada, and Florida markets. Notably, Florida operations now manage over 200,000 lives under value-based agreements, including more than 50,000 under Medicare Advantage.

#TOI #TOIIW The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown

www.stocktitan.net/news/TOI/the-oncology-in...

StockTitan

@stocktitan.net

1 year ago

#TOI #TOIIW The Oncology Institute Reports Third Quarter 2024 Financial Results

www.stocktitan.net/news/TOI/the-oncology-in...